Paper41300973
The Microbiome and Genitourinary Cancers: A New Frontier.
Winslow TB and 4 others. Cancers (Basel), 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. The Microbiome and Genitourinary Cancers: A New Frontier. Papers, record 41300973. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41300973
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References104
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38583184 | CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma. | Cancer Discov | 2024 | https://conductscience.org/library/papers/38583184 | PubMed |
| 2 | 33303685 | Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. | Science | 2021 | https://conductscience.org/library/papers/33303685 | PubMed |
| 3 | 38588588 | Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity. | Cancer Discov | 2024 | https://conductscience.org/library/papers/38588588 | PubMed |
| 4 | 34792538 | Treatment Selection in First-line Metastatic Renal Cell Carcinoma-The Contemporary Treatment Paradigm in the Age of Combination Therapy: A Review. | JAMA Oncol | 2022 | https://conductscience.org/library/papers/34792538 | PubMed |
| 5 | 37764869 | A Large Genetic Causal Analysis of the Gut Microbiota and Urological Cancers: A Bidirectional Mendelian Randomization Study. | Nutrients | 2023 | https://conductscience.org/library/papers/37764869 | PubMed |
| 6 | 26152743 | Stool Bacteriomic Profiling in Patients with Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitors. | Clin Cancer Res | 2015 | https://conductscience.org/library/papers/26152743 | PubMed |
| 7 | 37697271 | Causal associations between gut microbiota and urological tumors: a two-sample mendelian randomization study. | BMC Cancer | 2023 | https://conductscience.org/library/papers/37697271 | PubMed |
| 8 | 36398663 | Probiotics enhances anti-tumor immune response induced by gemcitabine plus cisplatin chemotherapy for urothelial cancer. | Cancer Sci | 2023 | https://conductscience.org/library/papers/36398663 | PubMed |
| 9 | 38024475 | Fecal microbiota transplantation plus tislelizumab and fruquintinib in refractory microsatellite stable metastatic colorectal cancer: an open-label, single-arm, phase II trial (RENMIN-215). | EClinicalMedicine | 2023 | https://conductscience.org/library/papers/38024475 | PubMed |
| 10 | 32297948 | Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors. | JAMA Netw Open | 2020 | https://conductscience.org/library/papers/32297948 | PubMed |
| 11 | 33850311 | Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids. | Cell Mol Immunol | 2021 | https://conductscience.org/library/papers/33850311 | PubMed |
| 12 | 30258117 | Regulation of the effector function of CD8+ T cells by gut microbiota-derived metabolite butyrate. | Sci Rep | 2018 | https://conductscience.org/library/papers/30258117 | PubMed |
| 13 | 38227898 | Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. | J Clin Oncol | 2024 | https://conductscience.org/library/papers/38227898 | PubMed |
| 14 | 38169949 | Microbial metabolites are involved in tumorigenesis and development by regulating immune responses. | Front Immunol | 2023 | https://conductscience.org/library/papers/38169949 | PubMed |
| 15 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 16 | 28260787 | Dysbiosis and the immune system. | Nat Rev Immunol | 2017 | https://conductscience.org/library/papers/28260787 | PubMed |
| 17 | 30675064 | A defined commensal consortium elicits CD8 T cells and anti-cancer immunity. | Nature | 2019 | https://conductscience.org/library/papers/30675064 | PubMed |
| 18 | 38652128 | Comparative investigation of neoadjuvant immunotherapy versus adjuvant immunotherapy in perioperative patients with cancer: a global-scale, cross-sectional, and large-sample informatics study. | Int J Surg | 2024 | https://conductscience.org/library/papers/38652128 | PubMed |
| 19 | 29311384 | Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment. | J Immunol | 2018 | https://conductscience.org/library/papers/29311384 | PubMed |
| 20 | 35039521 | Microbiome differential abundance methods produce different results across 38 datasets. | Nat Commun | 2022 | https://conductscience.org/library/papers/35039521 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42768754 | Long-Term or Recurrent Antibiotic Use During Childhood or Adolescence and the Risk of Kidney Cancer: A Cohort Study. | Cancer Med | 2026 | https://conductscience.org/library/papers/42768754 | PubMed |
| 41681968 | Decoding Microbiota in Genitourinary Oncology: Biological Mechanisms and Clinical Implications-A Narrative Review. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41681968 | PubMed |
| 41658610 | Decoding the microbial blueprint of pancreatic cancer. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/41658610 | PubMed |
| 41596284 | Dysbiosis-Mediated Regulation of Stem Cells the First Hit for Cancer Generation. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41596284 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41300973
GET https://conductscience.org/api/papers/v1/41300973/references?page=2